Hepatitis C: Indication for anti-viral therapy?

Transplant International

Volumn 9, Issue SUPPL. 1, 1996, Pages

  Platz, K P ^a   Mueller, A R ^a   Neuhaus, R ^a   Keck, H ^a   Lemmens, P ^a   Hopf, U ^a   Neuhaus, P ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Acute and chronic rejection; Hepatitis C; Liver transplantation

Indexed keywords

ANTIVIRUS AGENT; CYCLOSPORIN A; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER INJURY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MULTIPLE ORGAN FAILURE; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0029979867     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1996.tb01607.x     Document Type: Article

References (13)

1. Arnold JC, Kraus T, Otto G, et al (1992) Reccurrent hepatitis C virus after liver transplantation. Transplant Proc 24: 2646-2647
2. Feray C, Samuel D, Thiers V, et al (1992) Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 89: 1361-1365
3. Haller GW, Langrehr JM, Blumhardt G, et al (1995) Factors relevant to the development of primary dysfunction in liver allograft. Transplant Proc 27: 1192
4. König V, Bauditz J, Lobeck H, et al (1992) Hepatitis C reinfection after orthotopic liver transplantation. Hepatology 16: 1137-1143
5. Lake JR, Wright T, Ferrell L, et al (1993) Hepatitis B and C in liver transplantation. Transplant Proc 25: 2006-2009
6. Mueller AR, Platz K-P, Christe W, et al (1994) Severe neurotoxicity after liver transplantation: association between FK506 therapy and hepatitis C virus disease. Transplant Proc 26: 3131-3132
7. Mueller AR, Platz K-P, Bechstein WO, et al (1995) The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506. Clin Transpl 9: 176-184
8. Neuhaus P, Bechstein WO, Blumhardt G, et al (1993) Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibody. Transplantation 55: 1320-1327
9. Neuhaus P, Blumhardt G, Bechstein WO, et al (1995) Comparison of FK506-and cyclosporine A-based immunosuppression in primary orthotopic liver transplantation. A single center experience. Transplantation 59: 31-40
10. Poterucha JJ, Rakela J, Lumeng L, et al (1992) Diagnosis of chronic hepatitis C after liver transplantation by detection of viral sequences with polymerase chain reaction. Hepatology 15: 42-45
11. Shah G, Demetris AJ, Gavaler JS, et al (1992) Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. Gastroenterology 103: 323-324
12. Sheiner PA, Schwartz ME, Mor E, et al (1995) Severe or multiple rejection episodes are associated with early recur-rence of hepatitis C after liver transplantation. Hepatology 21: 30-34
13. Wright TL, Donegan E, Hsu HH, et al (1992) Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 103: 317-322